Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02116803 |
| Title | An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | ITA | ESP | BEL | AUT |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Novartis Investigative Site | Las Vegas | Nevada | 89169 | United States | Details | |
| Novartis Investigative Site | Bronx | New York | 10467-2490 | United States | Details | |
| Novartis Investigative Site | Salzburg | 5020 | Austria | Details | ||
| Novartis Investigative Site | Wilrijk | 2610 | Belgium | Details | ||
| Novartis Investigative Site | Copenhagen | DK-2100 | Denmark | Details | ||
| Novartis Investigative Site | Pavia | PV | 27100 | Italy | Details | |
| Novartis Investigative Site | Torino | TO | 10153 | Italy | Details | |
| Novartis Investigative Site | Osaka-city | Osaka | 545-8586 | Japan | Details | |
| Novartis Investigative Site | Palma De Mallorca | Islas Baleares | 07120 | Spain | Details |